1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

This BCC Research report discusses market growth, size and opportunities with respect to applications, geographic region and technologies. Forecast trends and revenue are given through 2019. Major players, applications and technologies, trends and market dynamics, competitive intelligence and geographic trends are also analyzed in the report.

Use this report to:
- Receive market analysis of the global SNP genotyping segments and subsegments by geographic regions, applications and technologies.
- Identify market trends, issues and factors impacting SNP genotyping market.
- Track alliances, joint ventures, mergers and acquisitions, new product developments, and research and development.
- Learn about the recent developments and the product portfolios of the major players.

Highlights
- The global single nucleotide polymorphism (SNP) genotyping market was valued at $3.5 billion in 2013. This market is expected to reach $4.3 billion in 2014 and $11.5 billion in 2019, compound annual growth rate (CAGR) of 21.9% from 2014 to 2019.
- The North American market is expected to increase from $1.8 billion in 2014 to $4.9 billion by 2019, at a CAGR of 21.8% from 2014 to 2019.
- The Asia-Pacific region is expected to grow the fastest from 2014 to 2019 with a CAGR of 24.1%, with revenue of $767.9 million in 2014 and about $2.3 billion in 2019.

Introduction & Scope

INTRODUCTION
The Global SNP Genotyping report discusses market growth, size and opportunities with respect to applications, geographic region and technologies. The report includes
forecast trends and revenue through 2019. Major players, applications and technologies, trends and market dynamics, competitive intelligence and geographic trends are well researched and analyzed in the report.

STUDY GOALS AND OBJECTIVES
- Define and discuss the global SNP genotyping market.
- Analyze market structure, segments and subsegments.
- Estimate market revenues of the global SNP genotyping segments and subsegments by geographic regions, applications and technologies.
- Identify market trends, issues and factors impacting SNP genotyping market.
- Study various submarkets with respect to growth drivers and inhibitors of the SNP genotyping market.
- Explain opportunities in the SNP genotyping market with respect to geographies and applications.
- Profile major players and analyze their core competencies and strategies in the SNP genotyping market.
- Track alliances, joint ventures, mergers and acquisitions, new product developments, and research and development in the global SNP genotyping market.

TITLE DESCRIPTION
SNP genotyping is a study of genetic differences in single nucleotide polymorphisms (SNPs) in cells and humans. It is the most widely used technique to discern variations
in the DNA sequence. DNA bases (A, T, C and G) comprise the 3-billion letter string of the human genome. The sequence of this string is almost always same for everyone.
Research has found that sometimes a single letter in the sequence may vary from one human to the other. SNP genotyping is the name given to the study of these DNA
variations between humans, and this practice has gained importance in medical diagnostics and research. SNPs are the fundamental markers in several human ailments and are therefore keenly studied in pharmacogenomics to better customize personalized medicine.

Researchers are confronted with the task of sorting out SNPs that correlate with specific influences on patients. Reliable findings will mean that such SNPs will function
as predictive markers for several dimensions of medical treatment, such as efficacy of and responsiveness to drugs. Such a pharmacogenetic methodology economizes on
time, money and distress for tens of thousands of patients by enabling precise diagnoses and appropriate medication.

SNPs assume great importance in view of their role in the identification of a person’s ancestry, susceptibility to disease, responsiveness to drugs, side effects experienced
and even how he or she looks or acts. SNPs are the most significant group of genetic changes that impact common diseases. Some studies suggest that nine out of the top
10 leading fatal diseases have a similar genetic makeup and actually one or more SNP controls the propensity to develop a particular disease.

SCOPE OF THE REPORT
This research report incorporates an in-depth analysis of the SNP genotyping market, including market estimations and trends through 2019. Major players, competitive
intelligence, technologies, applications, market dynamics and geographic opportunities are discussed in detail in the report. The report discusses recent developments and the product portfolios of the major players. Patent analysis in the report focuses on providing technological trends across the last few years in regions such as the U.S.,
Europe and Japan. The report presents market analysis and estimates CAGR (compound annual growth rate) for SNP genotyping technologies and geographies.

Table Of Contents

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
TITLE DESCRIPTION 2
SCOPE OF THE REPORT 3
MARKET STRUCTURE 3
INTENDED AUDIENCE 3
RESEARCH METHODOLOGY 3
ANALYST'S CREDENTIALS 4
RELATED BCC RESEARCH REPORTS 4
BCC RESEARCH WEBSITE 5
DISCLAIMER 5
CHAPTER 2 EXECUTIVE SUMMARY 7
SUMMARY TABLE GLOBAL MARKET FOR SNP GENOTYPING, THROUGH 2019 ($
MILLIONS) 8
SUMMARY FIGURE GLOBAL MARKET FOR SNP GENOTYPING, 2013-2019 ($
MILLIONS) 8
CHAPTER 3 MARKET OVERVIEW 11
INTRODUCTION 11
MARKET ANALYSIS 12
SNP FOR MUTATIONAL ANALYSIS 12
SNP DEFINITION 13
METHODS OF STUDYING SNPS 13
CLASSIFICATION OF SNPS: 13
USES OF SNPS: 14
MARKET DYNAMICS 14
DRIVERS 14
Decreasing Prices of DNA Sequencing 14
FIGURE 1 AVERAGE PRICE YOY TRENDS OF A GENOME, 2003-2012 ($) 14
Growing Global Prevalence of Cardiovascular Disease, Diabetes and
Cancer Triggering Demand for Developing Alternative and Relatively
More Permanent Therapeutic Solutions
15
FIGURE 2 PROJECTED PREVALENCE OF DIABETES, BY REGION, 2035 (% INCREASE
OVER 2013) 15
Growing Demand for Personalized Medicine and Growing Importance
of SNP Genotyping in the Drug Development Process 16
TABLE 1 USE OF SNP GENOTYPING DURING ALL THE STAGES OF DRUG
DEVELOPMENT 16
Increasing Demand for Genome Analysis in Animal and Plant
Livestock 16
RESTRAINTS 17
Lack of Appropriate Reimbursement Policies 17
MARKET ATTRACTIVENESS BY REGION 17
NORTH AMERICA 17
TABLE 2 LIST OF KEY ORGANIZATIONS FUNDING GENOMICS RELATED R andD
INITIATIVES IN THE U.S. 18
FIGURE 3 COUNTRY OF ORIGIN OF PUBLICLY TRADED GENOMICS FIRMS (%) 19
EUROPE 19
ASIA-PACIFIC 20
REST OF THE WORLD (ROW) 21
COMPETITIVE LANDSCAPE 21
INNOVATIONS AND CURRENT TRENDS 22
PUBLIC AND PRIVATE FUNDING 22
TABLE 3 MAJOR PRIVATE AND PUBLIC FUNDING ORGANIZATIONS 22
MARKET SHARE OF KEY PLAYERS 23
FIGURE 4 COMPANY MARKET SHARE, 2013 (%) 23
PATENT ANALYSIS 24
RECOMMENDATIONS 25
EXTENSIVE RandD INVESTMENTS 25
ACQUIRING EXTERNAL FUNDING 25
CONCLUSION 25
CHAPTER 4 GLOBAL SNP GENOTYPING MARKET BY TECHNOLOGY 28
OVERVIEW 28
TABLE 4 SNP GENOTYPING MARKET, BY TECHNOLOGIES, THROUGH 2019 ($
MILLIONS) 29
SNP GENOTYPING BY MICROARRAYS AND GENECHIPS 29
ILLUMINA 29
AFFYMETRIX 30
FLUIDIGM 30
TABLE 5 MICROARRAYS AND GENECHIPS MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 31
SEQUENOM MASSARRAY MALDI-TOF 31
TABLE 6 SEQUENOM MASSARRAY MALDI-TOF MARKET BY REGION, THROUGH 2019
($ MILLIONS) 32
SNP PYROSEQUENCING 32
TABLE 7 SNP PYROSEQUENCING MARKET BY REGION, THROUGH 2019 ($ MILLIONS) 32
APPLIED BIOSYSTEMS SNPLEX 33
TABLE 8 APPLIED BIOSYSTEMS SNPLEX MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 33
TAQMAN ALLELIC DISCRIMINATION 34
TABLE 9 TAQMAN ALLELIC DISCRIMINATION MARKET BY REGION, THROUGH 2019
($ MILLIONS) 35
OTHER SNP GENOTYPING TECHNOLOGIES 35
TABLE 10 OTHER SNP GENOTYPING TECHNOLOGIES MARKET BY REGION,
THROUGH 2019 ($ MILLIONS) 36
CHAPTER 5 SNP GENOTYPING MARKET BY APPLICATIONS 38
OVERVIEW 38
TABLE 11 GLOBAL SNP GENOTYPING MARKET BY APPLICATIONS, THROUGH 2019
($ MILLIONS) 38
PLANT IMPROVEMENT 39
SNPS ARE IMPORTANT FOR INCREASING CROP YIELD 40
TABLE 12 GLOBAL PLANT IMPROVEMNT MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 40
ANIMAL GENETICS 41
REDUCING COST OF SEQUENCING 42
IMPACT OF GENOMIC SELECTION IN ANIMALS 42
IMPLEMENTATION OF GENOMIC SELECTION 42
TRENDS 43
NEXT WAVE OF DISCOVERIES AND NEW APPROACHES 44
OPPORTUNITIES FOR DEVELOPING COUNTRIES 45
COST EFFECTIVENESS IN SEQUENCING WILL HELP FURTHER RESEARCH IN
ANIMALS 45
TABLE 13 GLOBAL ANIMAL GENETICS MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 46
PHARMACEUTICALS AND PHARMACOGENOMICS 46
LINKAGE AND ASSOCIATION STUDIES 47
PHARMACEUTICAL APPLICATIONS 47
SNP ARRAYS ARE USEFUL TOOLS FOR THE KNOW-HOW OF EVEN SLIGHT
DIFFERENCES AMONG WHOLE GENOMES 47
CONCLUSIONS 48
TABLE 14 GLOBAL PHARMACEUTICALS AND PHARMACOGENOMICS MARKET BY
REGION, THROUGH 2019 ($ MILLIONS) 49
DIAGNOSTIC RESEARCH 49
GENETIC RISK FACTORS 50
TABLE 15 GLOBAL DIAGNOSTICS RESEARCH MARKET BY REGION, THROUGH 2019
($ MILLIONS) 51
AGRICULTURAL BIOTECHNOLOGY 51
CASE STUDY 52
CONCLUSION 52
TABLE 16 GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION,
THROUGH 2019 ($ MILLIONS) 53
AQUACULTURE 53
TABLE 17 GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION,
THROUGH 2019 ($ MILLIONS) 54
OTHERS (HUMAN IDENTITY TESTING, HUMAN FORENSICS, CONSERVATION) 54
TABLE 18 GLOBAL OTHERS MARKET BY REGION, THROUGH 2019 ($ MILLIONS) 55
CHAPTER 6 SNP GENOTYPING MARKET BY REGION 57
OVERVIEW 57
NORTH AMERICA 57
TABLE 19 NORTH AMERICA SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH
2019 ($ MILLIONS) 58
EUROPE 58
TABLE 20 EUROPE SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($
MILLIONS) 59
ASIA-PACIFIC 59
TABLE 21 ASIA-PACFIC SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH
2019 ($ MILLIONS) 61
REST OF WORLD (ROW) 61
TABLE 22 ROW SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($
MILLIONS) 62
CHAPTER 7 COMPETITIVE LANDSCAPE 64
FIGURE 5 STRATEGIES FOLLOWED IN THE SNP GENOTYPING MARKET BY KEY
PLAYERS, 2011 TO APRIL 2014 (NUMBER) 64
TABLE 23 PRODUCT LAUNCHES IN SNP GENOTYPING MARKET, 2011-APRIL 2014 65
TABLE 24 JOINT VENTURES/ACQUISITIONS/AGREEMENTS IN THE SNP GENOTYPING
MARKET, 2011-APRIL 2014 70
TABLE 25 CERTIFICATION AND RESEARCH and DEVELOPMENT IN SNP GENOTYPING
MARKET, 2011-APRIL 2014 79
TABLE 26 EXPANSION/REORGANIZATION/OTHERS IN SNP GENOTYPING MARKET,
2011-APRIL 2014 81
CHAPTER 8 COMPANY PROFILES 83
AFFYMETRIX INC. 83
TABLE 27 PRODUCT PORTFOLIO 83
TABLE 28 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 84
AGILENT TECHNOLOGIES 86
TABLE 29 PRODUCT PORTFOLIO 87
TABLE 30 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 88
BECKMAN COULTER 88
TABLE 31 PRODUCT PORTFOLIO 89
TABLE 32 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 89
BIODISCOVERY 90
TABLE 33 PRODUCT PORTFOLIO 90
TABLE 34 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 91
BIO-RAD LABORATORIES 92
TABLE 35 PRODUCT PORTFOLIO 93
TABLE 36 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 93
COMBIMATRIX 94
TABLE 37 PRODUCT PORTFOLIO 95
TABLE 38 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 95
DOUGLAS SCIENTIFIC 96
TABLE 39 PRODUCT PORTFOLIO 96
TABLE 40 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 97
ENZO LIFE SCIENCES 97
TABLE 41 PRODUCT PORTFOLIO 98
TABLE 42 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 99
EPIGENDX 99
TABLE 43 PRODUCT PORTFOLIO 100
TABLE 44 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 100
FLUIDIGM CORP. 100
TABLE 45 PRODUCT PORTFOLIO 101
TABLE 46 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 102
GE HEALTHCARE 103
TABLE 47 PRODUCT PORTFOLIO 104
TABLE 48 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 104
ILLUMINA INC. 105
TABLE 49 PRODUCT PORTFOLIO 106
TABLE 50 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 107
LI-COR BIOSCIENCES 109
TABLE 51 PRODUCT PORTFOLIO 109
TABLE 52 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 110
LIFE TECHNOLOGIES (A BRAND OF THERMO FISHER SCIENTIFIC) 110
TABLE 53 PRODUCT PORTFOLIO 111
TABLE 54 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 111
OCIMUM BIOSOLUTIONS 112
TABLE 55 PRODUCT PORTFOLIO 112
TABLE 56 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 113
PREMIER BIOSOFT 113
TABLE 57 PRODUCT PORTFOLIO 113
TABLE 58 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 114
QIAGEN 114
TABLE 59 PRODUCT PORTFOLIO 115
TABLE 60 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 115
ROCHE 117
TABLE 61 PRODUCT PORTFOLIO 117
TABLE 62 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 118
SEQUENOM INC. 118
TABLE 63 PRODUCT PORTFOLIO 119
TABLE 64 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 119
SIGMA-ALDRICH 119
TABLE 65 PRODUCT PORTFOLIO 120
TABLE 66 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 120
CHAPTER 9 PATENT ANALYSIS 123
FIGURE 6 PATENTS BY REGION, 2011-JUNE 2014 (NUMBER) 123
TABLE 67 U.S. PATENTS, 2011-JUNE 2014 124
TABLE 68 EUROPEAN PATENTS, 2011-JUNE 2014 129
TABLE 69 JAPANESE PATENTS, 2011-JUNE 2014 132


LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR SNP GENOTYPING, THROUGH 2019 ($
MILLIONS) 8
TABLE 1 USE OF SNP GENOTYPING DURING ALL THE STAGES OF DRUG
DEVELOPMENT 16
TABLE 2 LIST OF KEY ORGANIZATIONS FUNDING GENOMICS RELATED R andD
INITIATIVES IN THE U.S. 18
TABLE 3 MAJOR PRIVATE AND PUBLIC FUNDING ORGANIZATIONS 22
TABLE 4 SNP GENOTYPING MARKET, BY TECHNOLOGIES, THROUGH 2019 ($
MILLIONS) 29
TABLE 5 MICROARRAYS AND GENECHIPS MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 31
TABLE 6 SEQUENOM MASSARRAY MALDI-TOF MARKET BY REGION, THROUGH 2019
($ MILLIONS) 32
TABLE 7 SNP PYROSEQUENCING MARKET BY REGION, THROUGH 2019 ($ MILLIONS) 32
TABLE 8 APPLIED BIOSYSTEMS SNPLEX MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 33
TABLE 9 TAQMAN ALLELIC DISCRIMINATION MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 35
TABLE 10 OTHER SNP GENOTYPING TECHNOLOGIES MARKET BY REGION, THROUGH
2019 ($ MILLIONS) 36
TABLE 11 GLOBAL SNP GENOTYPING MARKET BY APPLICATIONS, THROUGH 2019 ($
MILLIONS) 38
TABLE 12 GLOBAL PLANT IMPROVEMNT MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 40
TABLE 13 GLOBAL ANIMAL GENETICS MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 46
TABLE 14 GLOBAL PHARMACEUTICALS AND PHARMACOGENOMICS MARKET BY
REGION, THROUGH 2019 ($ MILLIONS) 49
TABLE 15 GLOBAL DIAGNOSTICS RESEARCH MARKET BY REGION, THROUGH 2019 ($
MILLIONS) 51
TABLE 16 GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION, THROUGH
2019 ($ MILLIONS) 53
TABLE 17 GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION, THROUGH
2019 ($ MILLIONS) 54
TABLE 18 GLOBAL OTHERS MARKET BY REGION, THROUGH 2019 ($ MILLIONS) 55
TABLE 19 NORTH AMERICA SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH
2019 ($ MILLIONS) 58
TABLE 20 EUROPE SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($
MILLIONS) 59
TABLE 21 ASIA-PACFIC SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019
($ MILLIONS) 61
TABLE 22 ROW SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($
MILLIONS) 62
TABLE 23 PRODUCT LAUNCHES IN SNP GENOTYPING MARKET, 2011-APRIL 2014 65
TABLE 24 JOINT VENTURES/ACQUISITIONS/AGREEMENTS IN THE SNP GENOTYPING
MARKET, 2011-APRIL 2014 70
TABLE 25 CERTIFICATION AND RESEARCH and DEVELOPMENT IN SNP GENOTYPING
MARKET, 2011-APRIL 2014 79
TABLE 26 EXPANSION/REORGANIZATION/OTHERS IN SNP GENOTYPING MARKET,
2011-APRIL 2014 81
TABLE 27 PRODUCT PORTFOLIO 83
TABLE 28 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 84
TABLE 29 PRODUCT PORTFOLIO 87
TABLE 30 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 88
TABLE 31 PRODUCT PORTFOLIO 89
TABLE 32 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 89
TABLE 33 PRODUCT PORTFOLIO 90
TABLE 34 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 91
TABLE 35 PRODUCT PORTFOLIO 93
TABLE 36 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 93
TABLE 37 PRODUCT PORTFOLIO 95
TABLE 38 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 95
TABLE 39 PRODUCT PORTFOLIO 96
TABLE 40 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 97
TABLE 41 PRODUCT PORTFOLIO 98
TABLE 42 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 99
TABLE 43 PRODUCT PORTFOLIO 100
TABLE 44 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 100
TABLE 45 PRODUCT PORTFOLIO 101
TABLE 46 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 102
TABLE 47 PRODUCT PORTFOLIO 104
TABLE 48 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 104
TABLE 49 PRODUCT PORTFOLIO 106
TABLE 50 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 107
TABLE 51 PRODUCT PORTFOLIO 109
TABLE 52 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 110
TABLE 53 PRODUCT PORTFOLIO 111
TABLE 54 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 111
TABLE 55 PRODUCT PORTFOLIO 112
TABLE 56 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 113
TABLE 57 PRODUCT PORTFOLIO 113
TABLE 58 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 114
TABLE 59 PRODUCT PORTFOLIO 115
TABLE 60 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 115
TABLE 61 PRODUCT PORTFOLIO 117
TABLE 62 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 118
TABLE 63 PRODUCT PORTFOLIO 119
TABLE 64 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 119
TABLE 65 PRODUCT PORTFOLIO 120
TABLE 66 RECENT DEVELOPMENTS, 2011 TO APRIL 2014 120
TABLE 67 U.S. PATENTS, 2011-JUNE 2014 124
TABLE 68 EUROPEAN PATENTS, 2011-JUNE 2014 129
TABLE 69 JAPANESE PATENTS, 2011-JUNE 2014 132


LIST OF FIGURES

SUMMARY FIGURE GLOBAL MARKET FOR SNP GENOTYPING, 2013-2019 ($ MILLIONS) 8
FIGURE 1 AVERAGE PRICE YOY TRENDS OF A GENOME, 2003-2012 ($) 14
FIGURE 2 PROJECTED PREVALENCE OF DIABETES, BY REGION, 2035 (% INCREASE
OVER 2013) 15
FIGURE 3 COUNTRY OF ORIGIN OF PUBLICLY TRADED GENOMICS FIRMS (%) 19
FIGURE 4 COMPANY MARKET SHARE, 2013 (%) 23
FIGURE 5 STRATEGIES FOLLOWED IN THE SNP GENOTYPING MARKET BY KEY
PLAYERS, 2011 TO APRIL 2014 (NUMBER) 64
FIGURE 6 PATENTS BY REGION, 2011-JUNE 2014 (NUMBER) 123

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Polymerase Chain Reaction (PCR) Technologies and Global Markets

Polymerase Chain Reaction (PCR) Technologies and Global Markets

  • $ 6650
  • Industry report
  • August 2016
  • by BCC Research

This BCC Research report explores the current and future PCR product market, which includes instruments, reagents and consumables, and software and services. It also looks at innovations, market drivers ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.